Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125651091 | 12565109 | 1 | I | 20160421 | 0 | 20160715 | 20160715 | DIR | 10.00 | YR | M | N | 55.00000 | KG | 20160714 | N | OT | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125651091 | 12565109 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | Y | D | 0 | 2.5 | MG | QD | ||||||
| 125651091 | 12565109 | 3 | C | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125651091 | 12565109 | 5 | C | TRILEPTAL | OXCARBAZEPINE | 1 | 0 | ||||||||||||
| 125651091 | 12565109 | 7 | C | DDAVP | DESMOPRESSIN ACETATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125651091 | 12565109 | 1 | Bipolar disorder |
| 125651091 | 12565109 | 1 | Oppositional defiant disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125651091 | 12565109 | Anxiety | |
| 125651091 | 12565109 | Dystonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125651091 | 12565109 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125651091 | 12565109 | 1 | 20160420 | 20160421 | 0 |